Home > Healthcare > Medical Devices > Implantable Devices > Neurovascular Embolization Market

Neurovascular Embolization Market Trends

  • Report ID: GMI7160
  • Published Date: Oct 2023
  • Report Format: PDF

Neurovascular Embolization Market Trends

Ongoing technological innovations in neurovascular embolization devices have enhanced treatment outcomes and patient safety. New materials, improved imaging techniques, and the development of more precise, minimally invasive devices have made the procedure more effective and accessible. For instance, in July 2023, MicroVention, Inc., released 5-year monitoring data for their intrasaccular device, WEB, and established two new sizes (SL 7x2 and SL 6x2) for aneurysm embolization technology, broadening its applicability to various aneurysm types and sizes. Such advancements attract healthcare providers and patients to opt for neurovascular embolization.

 

  • Furthermore, as awareness of the effectiveness and benefits of neurovascular embolization procedures rises among healthcare professionals and the public, there will be a growing demand for these treatments.
     
  • Additionally, improved knowledge about the availability and success of such procedures drives more patients to seek intervention for neurovascular conditions.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global neurovascular embolization industry was valued at USD 1.4 billion in 2022 and is estimated to account for USD 2.5 billion by 2032.

The embolic coils segment garnered USD 907 million in the year 2022, attributed to its proven clinical efficacy, minimally invasive nature, versatility, and ongoing technological advancements.

The U.S. neurovascular embolization market accounted for USD 503 million in 2022 and is predicted to witness substantial growth through 2032, primarily due to the advanced healthcare infrastructure, coupled with a high prevalence of neurovascular conditions, and the strong regulatory framework.

Medtronic, Stryker, Cerenovus (Johnson & Johnson), Integra LifeSciences, Penumbra Inc, Balt SAS, B. Braun Melsungen AG, Phenox GmbH, MicroVention Inc (Terumo Corporation), Shape Memory Medical Inc, Peter Lazic GmbH, and Spartan Micro.

Neurovascular Embolization Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 287
  • Countries covered: 18
  • Pages: 207
 Download Free Sample